Single chain variable fragment CD3 binding proteins
Disclosed herein are single chain variable fragment CD3 binding proteins with improved binding affinities, and robust aggregation profiles. Also described are multispecific binding proteins comprising a single chain variable fragment CD3 binding protein according to the instant disclosure. Pharmaceutical compositions comprising the binding proteins disclosed herein and methods of using such formulations are provided.
1. A single chain variable fragment CD3 binding protein, comprising a variable heavy chain region (VH), a variable light chain region (VL), and a linker, wherein VH comprises complementarity determining regions HC CDR1, HC CDR2, and HC CDR3, wherein VL comprises complementarity determining regions LC CDR1, LC CDR2, and LC CDR3, wherein the protein is at least eighty percent identical to SEQ ID NO: 22, wherein
(a) the amino acid sequence of HC CDR1 is as set forth in SEQ ID NO. 29, SEQ ID NO. 30, SEQ ID NO. 31, SEQ ID NO. 32, SEQ ID NO. 33, SEQ ID NO. 34, SEQ ID NO. 35, SEQ ID NO. 36, SEQ ID NO. 37, SEQ ID NO.38, SEQ ID NO. 39, or SEQ ID NO. 40;
(b) the amino acid sequence of HC CDR2 is as set forth in SEQ ID NO. 41, SEQ ID NO. 42, SEQ ID NO. 43, SEQ ID NO. 44, SEQ ID NO. 45, SEQ ID NO. 46, SEQ ID NO. 47, SEQ ID NO. 48, SEQ ID NO. 49, or SEQ ID NO. 50;
(c) the amino acid sequence of HC CDR3 is as set forth in SEQ ID NO. 51, SEQ ID NO. 52, SEQ ID NO. 53, SEQ ID NO. 54, SEQ ID NO. 55, SEQ ID NO. 56, SEQ ID NO. 57, SEQ ID NO. 58, SEQ ID NO. 59, or SEQ ID NO. 60;
(d) the amino acid sequence of LC CDR1 is as set forth in SEQ ID NO. 61, SEQ ID NO. 62, SEQ ID NO. 63, SEQ ID NO. 64, SEQ ID NO. 65, SEQ ID NO. 66, SEQ ID NO. 67, SEQ ID NO. 68, SEQ ID NO. 69, SEQ ID NO. 70, SEQ ID NO. 71, SEQ ID NO. 72, or SEQ ID NO: 73;
(e) the amino acid sequence of LC CDR2 is as set forth in SEQ ID NO. 74, SEQ ID NO. 75, SEQ ID NO. 76, SEQ ID NO. 77, SEQ ID NO. 78, SEQ ID NO. 79, SEQ ID NO. 80, SEQ ID NO. 81, SEQ ID NO. 82, SEQ ID NO. 83, SEQ ID NO. 84, SEQ ID NO. 85, or SEQ ID NO. 86; and
(f) the amino acid sequence of LC CDR3 is as set forth in SEQ ID NO. 87, SEQ ID NO: 88, SEQ ID NO. 89, SEQ ID NO. 90, SEQ ID NO. 91, SEQ ID NO. 92, or SEQ ID NO. 93, wherein said protein has an amino acid sequence that is at least about 95% identical to a sequence selected from the group consisting of: SEQ ID NO. 8, SEQ ID NO. 9, SEQ ID NO. 10, SEQ ID NO. 11, SEQ ID NO. 12, SEQ ID NO. 13, SEQ ID NO. 14, SEQ ID NO. 15, SEQ ID NO. 16, SEQ ID NO. 17, SEQ ID NO. 18, SEQ ID NO. 19, SEQ ID NO. 20, SEQ ID NO. 21, SEQ ID NO. 94, and SEQ ID NO. 95.
2. The single chain variable fragment CD3 binding protein of claim 1 , wherein HC CDR1 is SEQ ID NO. 39, HC CDR2 is SEQ ID NO. 49, HC CDR3 is SEQ ID NO. 51, LC CDR1 is SEQ ID NO. 61, LC CDR2 is SEQ ID NO. 86, and Fe LC CDR3 is SEQ ID NO. 87.
3. The single chain variable fragment CD3 binding protein of claim 1 , wherein HC CDR1 is SEQ ID NO. 30, HC CDR2 is SEQ ID NO. 43, LC CDR1 is SEQ ID NO. 64, and LC CDR3 is SEQ ID NO. 89.
4. The single chain variable fragment CD3 binding protein of claim 1 , wherein HC CDR3 is SEQ ID NO. 55, LC CDR1 is SEQ ID NO. 67, LC CDR2 is SEQ ID NO. 77, and LC CDR3 is SEQ ID NO. 92.
5. The single chain variable fragment CD3 binding protein of claim 1 , wherein HC CDR1 is SEQ ID NO. 31, HC CDR2 is SEQ ID NO. 42, HC CDR3 is SEQ ID NO. 60, LC CDR1 is SEQ ID NO. 64, LC CDR2 is SEQ ID NO. 79, and LC CDR3 is SEQ ID NO. 91.
6. The single chain variable fragment CD3 binding protein of claim 1 , wherein HC CDR1 is SEQ ID NO. 35, HC CDR2 is SEQ ID NO. 46, HC CDR3 is SEQ ID NO. 56, LC CDR1 is SEQ ID NO. 68, and LC CDR3 is SEQ ID NO. 75.
7. The single chain variable fragment CD3 binding protein of claim 1 , wherein HC CDR1 is SEQ ID NO. 29, HC CDR2 is SEQ ID NO. 44, HC CDR3 is SEQ ID NO. 52, LC CDR1 is SEQ ID NO. 73, and LC CDR2 is SEQ ID NO. 76.
8. The single chain variable fragment CD3 binding protein of claim 1 , wherein HC CDR1 is SEQ ID NO. 33, HC CDR2 is SEQ ID NO. 48, HC CDR3 is SEQ ID NO. 57, LC CDR1 is SEQ ID NO. 69, and LC CDR2 is SEQ ID NO. 74.
9. The single chain variable fragment CD3 binding protein of claim 1 , wherein HC CDR1 is SEQ ID NO. 37, HC CDR3 is SEQ ID NO. 53, LC CDR1 is SEQ ID NO. 70, LC CDR2 is SEQ ID NO. 82, and LC CDR3 is SEQ ID NO. 88.
10. The single chain variable fragment CD3 binding protein of claim 1 , wherein HC CDR1 is SEQ ID NO. 34, HC CDR2 is SEQ ID NO. 47, HC CDR3 is SEQ ID NO. 56, LC CDR1 is SEQ ID NO. 68 and LC CDR2 is SEQ ID NO. 75.
11. The single chain variable fragment CD3 binding protein of claim 1 , wherein HC CDR1 is SEQ ID NO. 29, HC CDR3 is SEQ ID NO. 54, LC CDR1 is SEQ ID NO. 71 and LC CDR2 is SEQ ID NO. 83.
12. The single chain variable fragment CD3 binding protein of claim 1 , wherein HC CDR1 is SEQ ID NO. 33, HC CDR2 is SEQ ID NO. 41, LC CDR1 is SEQ ID NO. 63, LC CDR2 is SEQ ID NO. 84, and LC CDR1 is SEQ ID NO. 90 or wherein HC CDR1 is SEQ ID NO. 30, HC CDR2 is SEQ ID NO. 44, HC CDR3 is SEQ ID NO. 58, LC CDR1 is SEQ ID NO. 66 and LC CDR2 is SEQ ID NO. 85.
13. The single chain variable fragment CD3 binding protein of claim 1 , wherein HC CDR1 is SEQ ID NO. 40, HC CDR2 is SEQ ID NO. 45, HC CDR3 is SEQ ID NO. 56, LC CDR2 is SEQ ID NO. 78 and LC CDR3 is SEQ ID NO. 93 or wherein HC CDR1 is SEQ ID NO. 36, HC CDR2 is SEQ ID NO. 50, HC CDR3 is SEQ ID NO. 59, LC CDR1 is SEQ ID NO. 72 and LC CDR2 is SEQ ID NO. 75.
14. The single chain variable fragment CD3 binding protein of claim 1 , wherein said protein has the amino acid sequence set forth as SEQ ID NO. 8.
15. The single chain variable fragment CD3 binding protein of claim 1 , wherein said protein has the amino acid sequence set forth as SEQ ID NO. 11.
16. The single chain variable fragment CD3 binding protein of claim 1 , wherein said protein has the amino acid sequence set forth as SEQ ID NO. 13.
17. The single chain variable fragment CD3 binding protein of claim 1 , wherein said protein has the amino acid sequence set forth as SEQ ID NO. 9.